MAM
Joydip Modak joins Times Network as associate account director
KOLKATA: Times Network has brought in seasoned media sales professional Joydip Modak as associate account director, tasking him with sharpening client partnerships and accelerating advertising revenue across key markets.
In his new role, Modak will lead strategic account management efforts while working closely with advertisers to craft integrated campaigns spanning television, radio, digital platforms and on-ground activations. The appointment signals Times Network’s continued push to strengthen cross-platform media solutions in an increasingly converged advertising landscape.
Modak arrives with more than a decade of experience across radio, television and corporate sales. Most recently, he served as business partner at Reliance Broadcast Network, where he handled corporate and key accounts across multiple cities. His tenure also included stints as senior account manager and corporate sales lead, focusing on retail, SME and institutional clients.
Before that, he worked with Fever FM under HT Media and earlier with GATI-KWE and ABP Group, building a career rooted in advertising sales, account development and new business generation.
With a track record that spans studios, boardrooms and brand pitches, Modak now steps into Times Network at a time when media plans increasingly demand one voice across many platforms. His brief is clear: keep clients close, ideas fresh and the revenue dial steadily moving north.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
